XML 16 R5.htm IDEA: XBRL DOCUMENT v3.22.4
Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Royalty revenues $ 386 $ 359
Costs and expenses:    
Research and development 27,107 17,376
Selling, general and administrative 13,181 11,838
Total operating expenses 40,288 29,214
Loss from operations (39,902) (28,855)
Other income (expense), net:    
Interest income, net 1,581 264
Other income (expense), net (383) 15
Gain from changes in fair value of derivative financial instruments—warrants 0 285
Total other income, net 1,198 564
Net loss (38,704) (28,291)
Preferred stock dividend payable on Series A Convertible Preferred Stock (24) (24)
Net loss attributable to common stockholders $ (38,728) $ (28,315)
Net loss per common share - basic (in dollars per share) $ (0.89) $ (0.73)
Net loss per common share - diluted (in dollars per share) $ (0.89) $ (0.73)
Weighted-average shares outstanding - basic (in shares) 43,600 39,030
Weighted-average shares outstanding - diluted (in shares) 43,600 39,030